16.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AUPH?
Forum
Prognose
Aktiensplit
Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten
MSN Money - MSN
Pharma Co. Investor Sues Over Misleading Aurinia Deal - Law360
Short Interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Decreases By 15.7% - MarketBeat
AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Screens Strong on Minervini Trend Template and High Growth Momentum - ChartMill
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
Kezar Life Sciences (NASDAQ: KZR) details Aurinia tender offer, pay and ownership - Stock Titan
Aurinia earnings on deck: Can new leadership sustain growth? By Investing.com - Investing.com India
Aurinia earnings on deck: Can new leadership sustain growth? - Investing.com
Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - MSN
Aurinia Pharmaceuticals acquiring Kezar Life Sciences - MSN
AUPH News | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - MSN
How (AUPH) Movements Inform Risk Allocation Models - Stock Traders Daily
Aurinia Pharmaceuticals stock hits 52-week high at $16.72 By Investing.com - Investing.com India
Aurinia Pharmaceuticals stock hits 52-week high at $16.72 - Investing.com Australia
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 1-Year HighStill a Buy? - MarketBeat
Aurinia (NASDAQ: AUPH) details 2026 virtual AGM, auditor and say-on-pay - Stock Titan
Aurinia (AUPH) Stock: Risk Exposure (Grinds Higher) 2026-04-18Viral Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Aurinia (AUPH) Stock Breakout Watch (-1.37%) 2026-04-16Risk Analysis - UBND thành phố Hải Phòng
Tudor Investment Corp ET AL Buys Shares of 65,964 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
How activist investor Kevin Tang finally landed the Bay Area company that got away from him - The Business Journals
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 12-Month HighHere's What Happened - MarketBeat
Trading Systems Reacting to (AUPH) Volatility - Stock Traders Daily
Aurinia to Acquire Kezar (NASDAQ: KZR) for $6.955 Cash plus CVR - Stock Titan
Ideas Watch: Is Aurinia Pharmaceuticals Inc gaining market sharePortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn
Guidance Update: Does Aurinia Pharmaceuticals Inc stock have upside surprise potentialBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Aurinia to buy Kezar (KZR) for $6.955/Share plus CVR (7.39M shares) - Stock Titan
Dow Update: Whats the profit margin of Aurinia Pharmaceuticals Inc2026 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Proxy StatementNotice of Shareholders Meeting (preliminary) (pre 14a) - ADVFN
Ritholtz Wealth Management Acquires 174,301 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
AUPHAurinia Announces Results of Annual General Meeting - ADVFN
RSI Check: Can Aurinia Pharmaceuticals Inc grow without external fundingDip Buying & Short-Term High Return Ideas - baoquankhu1.vn
Downgrade Watch: Why is Aurinia Pharmaceuticals Inc stock going up2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Stock Analysis: Will Aurinia Pharmaceuticals Inc benefit from government policyEarnings Risk Report & Risk Managed Trade Strategies - baoquankhu1.vn
7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments - GlobeNewswire Inc.
Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - Sahm
AUPH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):